Bellone, S.; McNamara, B.; Mutlu, L.; Demirkiran, C.; Hartwich, T.M.P.; Harold, J.; Yang-Hartwich, Y.; Siegel, E.R.; Santin, A.D.
Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers. Int. J. Mol. Sci. 2023, 24, 8873.
https://doi.org/10.3390/ijms24108873
AMA Style
Bellone S, McNamara B, Mutlu L, Demirkiran C, Hartwich TMP, Harold J, Yang-Hartwich Y, Siegel ER, Santin AD.
Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers. International Journal of Molecular Sciences. 2023; 24(10):8873.
https://doi.org/10.3390/ijms24108873
Chicago/Turabian Style
Bellone, Stefania, Blair McNamara, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Eric R. Siegel, and Alessandro D. Santin.
2023. "Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers" International Journal of Molecular Sciences 24, no. 10: 8873.
https://doi.org/10.3390/ijms24108873
APA Style
Bellone, S., McNamara, B., Mutlu, L., Demirkiran, C., Hartwich, T. M. P., Harold, J., Yang-Hartwich, Y., Siegel, E. R., & Santin, A. D.
(2023). Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers. International Journal of Molecular Sciences, 24(10), 8873.
https://doi.org/10.3390/ijms24108873
